Enovis Corp (LTS:0I1B)
$ 44.93 0.39 (0.88%) Market Cap: 2.47 Bil Enterprise Value: 3.82 Bil PE Ratio: 0 PB Ratio: 0.75 GF Score: 68/100

Enovis Corp at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 03:40PM GMT
Release Date Price: $55.05
Jamie Aaron Perse
Goldman Sachs Group, Inc., Research Division - Associate

Good morning, everyone. I'm Jamie Perse. Thank you for joining Day 2 of the Goldman Healthcare Conference. Our next panel is with Enovis. We have CEO, Matt Trerotola, CFO, Ben Berry; and in the audience, we've got IR, Derek Leckow. Thank you for joining.

Matthew L. Trerotola
Enovis Corporation - CEO & Chairman

Thank you. Great to be here. Thanks.

Questions & Answers

Jamie Aaron Perse
Goldman Sachs Group, Inc., Research Division - Associate

Maybe we could start, I mean, I think investors are still getting up to speed on the company, and maybe you could just say a few words about the high-level story and where you guys are at today?

Matthew L. Trerotola
Enovis Corporation - CEO & Chairman

Yes, sure. Thanks. We're a focused med tech innovation-driven growth company, a little over $1.5 billion of revenues. We were created a little over a year ago by a separation from Colfax,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot